Ad
Monday, 19 December 2016
Richter withdraws marketing application for biosimilar drug
BUDAPEST (Reuters) - Hungarian pharmaceuticals firm Richter has withdrawn its marketing application for one of its biosimilar drugs from the European Medicines Agency in anticipation of a possible negative assessment, the company said on Monday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment